Rectifying rectifier channels in Huntington disease

References

• Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 2014; 10:204 - 16; http://dx.doi.org/10.1038/nrneurol.2014.24; PMID: 24614516
   PubMed Web of Science ®Google Scholar
• G H. On Chorea. Med Surg Rep 1872; 26:317 - 21
   Google Scholar
• Walker FO. Huntington’s Disease. Semin Neurol 2007; 27:143 - 50; http://dx.doi.org/10.1055/s-2007-971176; PMID: 17390259
   PubMed Web of Science ®Google Scholar
• Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jette N. The incidence and prevalence of Huntington’s disease: a systematic review and meta-analysis. Mov Disord 2012; 27:1083 - 91; http://dx.doi.org/10.1002/mds.25075; PMID: 22692795
   PubMed Web of Science ®Google Scholar
• Maragakis NJ, Rothstein JD. Mechanisms of Disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2006; 2:679 - 89; http://dx.doi.org/10.1038/ncpneuro0355; PMID: 17117171
   PubMedGoogle Scholar
• Proft J, Weiss N. A protective mutation against Alzheimer disease?. Commun Integr Biol 2012; 5:301 - 3; http://dx.doi.org/10.4161/cib.21799; PMID: 23060947
   PubMedGoogle Scholar
• Proft J, Weiss N. Jekyll and Hide: The two faces of amyloid β. Commun Integr Biol 2012; 5:405 - 7; http://dx.doi.org/10.4161/cib.22571; PMID: 23181153
   PubMedGoogle Scholar
• Goehler H, Lalowski M, Stelzl U, Waelter S, Stroedicke M, Worm U, Droege A, Lindenberg KS, Knoblich M, Haenig C, et al. A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington’s disease. Mol Cell 2004; 15:853 - 65; http://dx.doi.org/10.1016/j.molcel.2004.09.016; PMID: 15383276
   PubMed Web of Science ®Google Scholar
• Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 2005; 171:1001 - 12; http://dx.doi.org/10.1083/jcb.200508072; PMID: 16365166
   PubMed Web of Science ®Google Scholar
• Faideau M, Kim J, Cormier K, Gilmore R, Welch M, Auregan G, Dufour N, Guillermier M, Brouillet E, Hantraye P, et al. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington’s disease subjects. Hum Mol Genet 2010; 19:3053 - 67; http://dx.doi.org/10.1093/hmg/ddq212; PMID: 20494921
   PubMed Web of Science ®Google Scholar
• Proft J, Weiss N. T-type Ca(2+) channels: New players in the aging brain. Commun Integr Biol 2014; 7:e28424; http://dx.doi.org/10.4161/cib.28424; PMID: 24748914
   PubMedGoogle Scholar
• Tong X, Ao Y, Faas GC, Nwaobi SE, Xu J, Haustein MD, Anderson MA, Mody I, Olsen ML, Sofroniew MV, et al. Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington’s disease model mice. Nat Neurosci 2014; 17:694 - 703; http://dx.doi.org/10.1038/nn.3691; PMID: 24686787
   PubMed Web of Science ®Google Scholar
• Higashi K, Fujita A, Inanobe A, Tanemoto M, Doi K, Kubo T, Kurachi Y. An inwardly rectifying K(+) channel, Kir4.1, expressed in astrocytes surrounds synapses and blood vessels in brain. Am J Physiol Cell Physiol 2001; 281:C922 - 31; PMID: 11502569
   PubMed Web of Science ®Google Scholar
• Poopalasundaram S, Knott C, Shamotienko OG, Foran PG, Dolly JO, Ghiani CA, Gallo V, Wilkin GP. Glial heterogeneity in expression of the inwardly rectifying K(+) channel, Kir4.1, in adult rat CNS. Glia 2000; 30:362 - 72; http://dx.doi.org/10.1002/(SICI)1098-1136(200006)30:4<362::AID-GLIA50>3.0.CO;2-4; PMID: 10797616
   PubMed Web of Science ®Google Scholar
• Barres BA, Koroshetz WJ, Chun LL, Corey DP. Ion channel expression by white matter glia: the type-1 astrocyte. Neuron 1990; 5:527 - 44; http://dx.doi.org/10.1016/0896-6273(90)90091-S; PMID: 1698397
   PubMed Web of Science ®Google Scholar
• Bockenhauer D, Feather S, Stanescu HC, Bandulik S, Zdebik AA, Reichold M, Tobin J, Lieberer E, Sterner C, Landoure G, et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med 2009; 360:1960 - 70; http://dx.doi.org/10.1056/NEJMoa0810276; PMID: 19420365
   PubMed Web of Science ®Google Scholar
• Zerangue N, Kavanaugh MP. Flux coupling in a neuronal glutamate transporter. Nature 1996; 383:634 - 7; http://dx.doi.org/10.1038/383634a0; PMID: 8857541
   PubMed Web of Science ®Google Scholar
• Danbolt NC. Glutamate uptake. Prog Neurobiol 2001; 65:1 - 105; http://dx.doi.org/10.1016/S0301-0082(00)00067-8; PMID: 11369436
   PubMed Web of Science ®Google Scholar
• Parsons MP, Raymond LA. Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron 2014; 82:279 - 93; http://dx.doi.org/10.1016/j.neuron.2014.03.030; PMID: 24742457
   PubMed Web of Science ®Google Scholar
• Wilcock DM, Vitek MP, Colton CA. Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer’s disease. Neuroscience 2009; 159:1055 - 69; http://dx.doi.org/10.1016/j.neuroscience.2009.01.023; PMID: 19356689
   PubMed Web of Science ®Google Scholar